Literature DB >> 16328227

Mucormycosis spondylodiscitis after lumbar disc puncture.

Fei Chen1, Guohua Lü, Yijun Kang, Zeming Ma, Chang Lu, Bin Wang, Jin Li, Jun Liu, Haisheng Li.   

Abstract

Vertebral osteomyelitis due to mucormycosis is a rare but fulminant and fatal disease. Only one case has been reported in literature, with postmortem diagnosis. The present paper reports a female case of mucormycosis spondylodiscitis and vertebral osteomyelitis after lumbar disc puncture and radio frequency nucleoplasty. She subsequently underwent two surgical debridements, continuous local irrigation and drainage, together with local and systemic Amphotericin B treatments. The infection was controlled 4 months after the second debridement; however, there was no improvement in the neurological function at the most recent follow-up, 16 months after the surgery. The experience of this patient, though a single case, supports early recognition, surgical debridement, systemic and local antifungal treatment, closed irrigation and drainage as the keys to successful treatment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16328227      PMCID: PMC3489305          DOI: 10.1007/s00586-005-1025-0

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  20 in total

Review 1.  Disseminated zygomycosis: report of four cases and review.

Authors:  C W Ingram; J Sennesh; J N Cooper; J R Perfect
Journal:  Rev Infect Dis       Date:  1989 Sep-Oct

2.  Mucormycosis in allogeneic bone marrow transplant recipients: report of five cases and review of the role of iron overload in the pathogenesis.

Authors:  J Maertens; H Demuynck; E K Verbeken; P Zachée; G E Verhoef; P Vandenberghe; M A Boogaerts
Journal:  Bone Marrow Transplant       Date:  1999-08       Impact factor: 5.483

3.  Fungal osteomyelitis of the foot. A report of an unusual case.

Authors:  C J Shaw; A J Thomason; J D Spencer
Journal:  J Bone Joint Surg Br       Date:  1994-01

4.  Nosocomial infection with Rhizopus microsporus in preterm infants: association with wooden tongue depressors.

Authors:  S J Mitchell; J Gray; M E Morgan; M D Hocking; G M Durbin
Journal:  Lancet       Date:  1996-08-17       Impact factor: 79.321

5.  Randomized, double-blind clinical trial of amphotericin B colloidal dispersion vs. amphotericin B in the empirical treatment of fever and neutropenia.

Authors:  M H White; R A Bowden; E S Sandler; M L Graham; G A Noskin; J R Wingard; M Goldman; J A van Burik; A McCabe; J S Lin; M Gurwith; C B Miller
Journal:  Clin Infect Dis       Date:  1998-08       Impact factor: 9.079

6.  Mucormycosis: experience with 10 patients.

Authors:  T Shpitzer; Y Stern; Y Anavi; K Segal; R Feinmesser
Journal:  Clin Otolaryngol Allied Sci       Date:  1995-08

Review 7.  Mucormycosis in trauma patients.

Authors:  C S Cocanour; P Miller-Crotchett; R L Reed; P C Johnson; R P Fischer
Journal:  J Trauma       Date:  1992-01

Review 8.  Invasive infection due to Apophysomyces elegans in immunocompetent hosts.

Authors:  W G Weinberg; B H Wade; G Cierny; D Stacy; M G Rinaldi
Journal:  Clin Infect Dis       Date:  1993-11       Impact factor: 9.079

Review 9.  Mucormycosis (zygomycosis): is there news for the clinician?

Authors:  J R Boelaert
Journal:  J Infect       Date:  1994-05       Impact factor: 6.072

Review 10.  Severe osteomyelitis due to the zygomycete Apophysomyces elegans.

Authors:  J F Meis; B J Kullberg; M Pruszczynski; R P Veth
Journal:  J Clin Microbiol       Date:  1994-12       Impact factor: 5.948

View more
  11 in total

Review 1.  Postoperative spondilodiscitis.

Authors:  Antoine Gerometta; Fabian Bittan; Juan Carlos Rodriguez Olaverri
Journal:  Int Orthop       Date:  2012-02-04       Impact factor: 3.075

2.  Invited commentary.

Authors:  Phil S Sizer
Journal:  J Man Manip Ther       Date:  2008

Review 3.  Bone and joint infections caused by mucormycetes: A challenging osteoarticular mycosis of the twenty-first century.

Authors:  Saad J Taj-Aldeen; Maria N Gamaletsou; Blandine Rammaert; Nikolaos V Sipsas; Valerie Zeller; Emmanuel Roilides; Dimitrios P Kontoyiannis; Michael Henry; Vidmantas Petraitis; Brad Moriyama; David W Denning; Olivier Lortholary; Thomas J Walsh
Journal:  Med Mycol       Date:  2017-10-01       Impact factor: 4.076

4.  Spondylodiscitis associated with skin lesions caused by Rhizopus in a patient with systemic lupus erythematosus.

Authors:  Larissa Silva de Saboya; Moara Alves Santa Bárbara Borges; Diego Gonçalves Camargo; Maria Auxiliadora de Paula Carneiro Cysneiros; Murilo Eugênio Oliveira; Adriana Oliveira Guilarde
Journal:  Infez Med       Date:  2022-03-01

Review 5.  Paraplegia secondary to disseminated mucormycosis: case report and literature review.

Authors:  Xiangjun Shi; Lei Qi; Boran Du; Xingchen Yao; Xinru Du
Journal:  BMC Infect Dis       Date:  2022-04-25       Impact factor: 3.667

6.  Spinal Mucormycosis.

Authors:  Kunal Shah; Abhay Nene
Journal:  J Glob Infect Dis       Date:  2017 Oct-Dec

Review 7.  Conventional Antifungals for Invasive Infections Delivered by Unconventional Methods; Aerosols, Irrigants, Directed Injections and Impregnated Cement.

Authors:  Richard H Drew; John R Perfect
Journal:  J Fungi (Basel)       Date:  2022-02-21

8.  Spondylodiscitis after Cervical Nucleoplasty without Any Abnormal Laboratory Findings.

Authors:  Seung Jun Lee; Eun Joo Choi; Francis Sahngun Nahm
Journal:  Korean J Pain       Date:  2013-04-03

9.  Isolated Mucormycotic Spondylodiscitis of Lumbar Spine-A Rare Case Report.

Authors:  Shailesh Hadgaonkar; Kunal Shah; Shekhar Bhojraj; Abhay Nene; Ashok Shyam
Journal:  J Orthop Case Rep       Date:  2015 Apr-Jun

Review 10.  Osteoarticular Infections Caused by Non-Aspergillus Filamentous Fungi in Adult and Pediatric Patients: A Systematic Review.

Authors:  Saad J Taj-Aldeen; Blandine Rammaert; Maria Gamaletsou; Nikolaos V Sipsas; Valerie Zeller; Emmanuel Roilides; Dimitrios P Kontoyiannis; Andy O Miller; Vidmantas Petraitis; Thomas J Walsh; Olivier Lortholary
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.